These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 2351829)

  • 21. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
    Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
    Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel immunostimulator, N-[alpha-O-benzyl-N-(acetylmuramyl)-L-alanyl-D-isoglutaminyl]-N6-trans-(m-nitrocinnamoyl)-L-lysine, and its adjuvancy on the hepatitis B surface antigen.
    Yang HZ; Xu S; Liao XY; Zhang SD; Liang ZL; Liu BH; Bai JY; Jiang C; Ding J; Cheng GF; Liu G
    J Med Chem; 2005 Aug; 48(16):5112-22. PubMed ID: 16078831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I; Willems A; Gijbels Y; Leroux-Roels G
    J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
    Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
    J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA.
    Leclerc C; Dériaud E; Rojas M; Whalen RG
    Cell Immunol; 1997 Aug; 179(2):97-106. PubMed ID: 9268493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
    Shimizu Y; Guidotti LG; Fowler P; Chisari FV
    J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cationic transfersomes based topical genetic vaccine against hepatitis B.
    Mahor S; Rawat A; Dubey PK; Gupta PN; Khatri K; Goyal AK; Vyas SP
    Int J Pharm; 2007 Aug; 340(1-2):13-9. PubMed ID: 17446015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Algammulin (gamma inulin/alum hybrid adjuvant) has greater adjuvanticity than alum for hepatitis B surface antigen in mice.
    Cooper PD; Turner R; McGovern J
    Immunol Lett; 1991 Feb; 27(2):131-4. PubMed ID: 1827427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CPG ODN allows lower dose of antigen against hepatitis B surface antigen in BALB/c mice.
    Weeratna R; Comanita L; Davis HL
    Immunol Cell Biol; 2003 Feb; 81(1):59-62. PubMed ID: 12534947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant effect of polyadenylic.polyuridylic acid on antibody production of recombinant hepatitis B surface antigen in mice.
    Park SJ; Kim WH; Han KH; Chon CY; Hahm KB; Moon YM; Kang JK; Park IS; Youn JK
    Int J Immunopharmacol; 1995 Jun; 17(6):513-6. PubMed ID: 7499028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgE responses to synthetic polypeptide antigens. I. Simultaneous Ir gene and isotype-specific regulation of IgE responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT).
    Dessein A; Germain RN; Dorf ME; Benacerraf B
    J Immunol; 1979 Jul; 123(1):463-70. PubMed ID: 109538
    [No Abstract]   [Full Text] [Related]  

  • 34. Enhancement by murabutide of the immune response to natural and synthetic hepatitis B surface antigens.
    Audibert FM; Przewlocki G; Leclerc CD; Jolivet ME; Gras-Masse HS; Tartar AL; Chedid LA
    Infect Immun; 1984 Jul; 45(1):261-6. PubMed ID: 6735468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A potent adjuvant effect of CD40 antibody attached to antigen.
    Barr TA; McCormick AL; Carlring J; Heath AW
    Immunology; 2003 May; 109(1):87-92. PubMed ID: 12709021
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Further studies on the adjuvanticity of stearyl tyrosine and amide analogues.
    Penney CL; Dionne G; Nixon-George A; Bona CA
    Vaccine; 1994 May; 12(7):629-32. PubMed ID: 8085381
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IgE antibody against hepatitis B surface antigen in mice.
    Uchida T; Nariuchi H; Matuhasi T
    Jpn J Med Sci Biol; 1985 Feb; 38(1):19-23. PubMed ID: 4021174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the immunoadjuvant octadecyl tyrosine hydrochloride.
    Penney CL; Landi S; Shah P; Leung KH; Archer MC
    J Biol Stand; 1986 Oct; 14(4):345-9. PubMed ID: 3558418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. l-Tyrosine as an immunological adjuvant.
    Wheeler AW; Moran DM; Robins BE; Driscoll A
    Int Arch Allergy Appl Immunol; 1982; 69(2):113-9. PubMed ID: 7107028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative adjuvant action of gamma insulin and alum.
    Cooper PD; Gust ID; Steele EJ; Leslie DE
    Immunol Cell Biol; 1991 Feb; 69 ( Pt 1)():57. PubMed ID: 1869290
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.